For citations:
Ruyatkina L.A., Ruyatkin D.S. Subclinical hypothyroidism and metabolic syndrome: reasons for drug intervention. Obesity and metabolism. 2020;17(1):41-47. (In Russ.) https://doi.org/10.14341/omet12282
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
